Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck Cancer
Clinical trial NCT02383966 · COMPLETED
Trial details
- NCT number
- NCT02383966
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-31
- Primary completion
- 2018-01-19
- Enrollment
- 243
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.